相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Residual risk of liver disease after hepatitis C virus eradication
Francesco Negro
JOURNAL OF HEPATOLOGY (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
Hepatocellular carcinoma risk in hepatitis C stage-3 fibrosis after sustained virological response with direct-acting antivirals
Maria Sanchez-Azofra et al.
LIVER INTERNATIONAL (2021)
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Mattias Mandorfer et al.
HEPATOLOGY (2020)
Intrahepatic immune changes after hepatitis c virus eradication by direct-acting antiviral therapy
Giuliana Amaddeo et al.
LIVER INTERNATIONAL (2020)
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals
Monica Pons et al.
JOURNAL OF HEPATOLOGY (2020)
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
Manuel Mendizabal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Angelo Sangiovanni et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Sabela Lens et al.
JOURNAL OF HEPATOLOGY (2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan et al.
JOURNAL OF HEPATOLOGY (2020)
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025
Sergio Rodriguez-Tajes et al.
JOURNAL OF HEPATOLOGY (2020)
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
Etienne Audureau et al.
JOURNAL OF HEPATOLOGY (2020)
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis
Sonia Alonso Lopez et al.
HEPATOLOGY (2020)
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
George N. Ioannou et al.
JAMA NETWORK OPEN (2020)
The Nobel Prize in Medicine 2020 for the Discovery of Hepatitis C Virus: Transforming Hepatology
Thomas F. Baumert
JOURNAL OF HEPATOLOGY (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease
Lisa I. Backus et al.
HEPATOLOGY (2019)
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
Zoe Marino et al.
JOURNAL OF HEPATOLOGY (2019)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
Marco Sanduzzi-Zamparelli et al.
VIRUSES-BASEL (2019)
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
Elisabetta Degasperi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire et al.
HEPATOLOGY (2018)
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
Gonzalo Crespo et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
Sujan Ravi et al.
GASTROENTEROLOGY (2017)
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Sabela Lens et al.
GASTROENTEROLOGY (2017)
Extrahepatic and Intrahepatic Malignancies in Patients With HCV Who Achieve an SVR With Directly Acting Antiviral Agents: Should We be Concerned that DAA Therapy Contributed to this Phenomenon?
Paul J. Gaglio
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
Lauren A. Beste et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension
N. Afdhal et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
Maria Reig et al.
SEMINARS IN LIVER DISEASE (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Non invasive tools for the diagnosis of liver cirrhosis
Maurizio Soresi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors
Elba Llop et al.
JOURNAL OF HEPATOLOGY (2012)
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease
C. Bureau et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Severe liver fibrosis or cirrhosis: Accuracy of US for detection - Analysis of 300 cases
A Colli et al.
RADIOLOGY (2003)